Neuromedical
PrivateLast Round
Seed
Feb 17, 2026
Total Funding Raised
$2.58M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Neuromedical operates in Healthcare & Life Sciences and is based in Poland. Its latest recorded funding round was a Seed round in February 2026.
Neuromedical is a medical device company that develops VGuard, a non-invasive transcutaneous vagus nerve stimulation system designed for the treatment of mild cognitive impairment and early-stage Alzheimer's disease.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Patient Engagement, Healthcare Analytics
Business Model
B2B2C
Customer Profile
Hardware + Subscription
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neuromedical Comparables
Compare Neuromedical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| tVNS Technologies GmbH | 78% | |
| Cognito Therapeutics | 74% | |
| Vagustim | 66% |
For institutional investors. Book with your work email.
Neuromedical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 17, 2026 | ||||
| Seed | May 20, 2025 | ||||
| Seed | May 17, 2020 |
For institutional investors. Book with your work email.
Neuromedical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| INNOventure | Seed |
| Hard2beat | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 18, 2026
Raised $1.54M in a Seed round.
For institutional investors. Book with your work email.
Neuromedical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Neuromedical's valuation, stock price, and market status.
Is Neuromedical a public or private company?
Neuromedical is a private company.
What is the current stock price of Neuromedical?
Neuromedical is a private company, so its shares have no public market price. Caplight tracks Neuromedical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Neuromedical worth (valuation)?
Valuation information for Neuromedical is not publicly available.
Can I buy Neuromedical stock?
Neuromedical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Neuromedical's last funding round?
Neuromedical's most recent funding round was Seed on February 17, 2026.
Who are the main investors in Neuromedical?
Key investors in Neuromedical include Hard2beat.
Will Neuromedical IPO soon?
No public IPO plans have been announced for Neuromedical.
How can I track Neuromedical secondary market activity?
Caplight tracks bids, offers, and trades in Neuromedical's shares on secondary markets.